Genor Biopharma Holdings Limited
HKEX:6998.HK
1.65 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||||
Current Assets: | |||||||||||||||||||
Cash & Cash Equivalents
| 1,026.567 | 1,026.567 | 1,165.481 | 1,165.481 | 1,361.971 | 1,361.971 | 1,588.705 | 1,588.705 | 1,858.181 | 1,858.181 | 2,200.641 | 2,200.641 | 2,579.149 | 2,579.149 | 2,929.743 | 2,929.743 | -196.836 | 196.836 | -125.158 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 393.672 | 0 | 250.316 |
Cash and Short Term Investments
| 1,026.567 | 1,026.567 | 1,165.481 | 1,165.481 | 1,361.971 | 1,361.971 | 1,588.705 | 1,588.705 | 1,858.181 | 1,858.181 | 2,200.641 | 2,200.641 | 2,579.149 | 2,579.149 | 2,929.743 | 2,929.743 | 196.836 | 196.836 | 125.158 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 5.501 | 5.501 | 5.667 | 5.667 | 33.644 | 33.644 | 47.404 | 47.404 | 46.496 | 46.496 | 49.653 | 49.653 | 43.679 | 43.679 | 31.465 | 31.465 | 0 | 23.055 | 0 |
Other Current Assets
| 60.133 | 60.133 | 69.975 | 69.975 | 69.648 | 69.648 | 84.044 | 84.044 | 92.32 | 92.32 | 136.284 | 136.284 | 116.654 | 116.654 | 140.199 | 140.199 | 0 | 76.823 | 0 |
Total Current Assets
| 1,092.201 | 1,092.201 | 1,241.123 | 1,241.123 | 1,465.263 | 1,465.263 | 1,720.153 | 1,720.153 | 1,996.997 | 1,996.997 | 2,386.578 | 2,386.578 | 2,739.482 | 2,739.482 | 3,101.407 | 3,101.407 | 196.836 | 296.714 | 125.158 |
Non-Current Assets: | |||||||||||||||||||
Property, Plant & Equipment, Net
| 41.896 | 41.896 | 60.137 | 60.137 | 193.954 | 193.954 | 205.217 | 205.217 | 243.77 | 243.77 | 223.367 | 223.367 | 217.677 | 217.677 | 229.163 | 229.163 | 0 | 220.195 | 0 |
Goodwill
| 0 | 0 | 17.819 | 17.819 | 17.819 | 17.819 | 21.753 | 21.753 | 0 | 0 | 21.753 | 21.753 | 21.753 | 21.753 | 21.753 | 21.753 | 0 | 21.753 | 0 |
Intangible Assets
| 104.458 | 104.458 | 92.28 | 92.28 | 127.206 | 127.206 | 141.455 | 141.455 | 166.486 | 166.486 | 149.29 | 149.29 | 149.586 | 149.586 | 135.183 | 135.183 | 0 | 74.064 | 0 |
Goodwill and Intangible Assets
| 104.458 | 104.458 | 110.099 | 110.099 | 145.025 | 145.025 | 163.208 | 163.208 | 166.486 | 166.486 | 171.043 | 171.043 | 171.339 | 171.339 | 156.936 | 156.936 | 0 | 95.817 | 0 |
Long Term Investments
| 0 | 0 | -8.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 8.35 | 0 | 7.608 | 0 | 6.913 | 0 | 7.944 | 0 | 5.732 | 0 | 9.171 | 0 | 0 | 0 | 0 | 1.509 | 0 |
Other Non-Current Assets
| 35.766 | 35.766 | 35.518 | 35.518 | 22.649 | 30.257 | 19.6 | 26.513 | 12.539 | 20.483 | 76.121 | 81.853 | 136.443 | 145.614 | 85.943 | 85.943 | -196.836 | 64.948 | -125.158 |
Total Non-Current Assets
| 182.12 | 182.12 | 205.754 | 205.754 | 369.236 | 369.236 | 394.938 | 394.938 | 430.739 | 430.739 | 476.263 | 476.263 | 534.63 | 534.63 | 472.042 | 472.042 | -196.836 | 382.469 | -125.158 |
Total Assets
| 1,274.321 | 1,274.321 | 1,446.877 | 1,446.877 | 1,834.499 | 1,834.499 | 2,115.091 | 2,115.091 | 2,427.736 | 2,427.736 | 2,862.841 | 2,862.841 | 3,274.112 | 3,274.112 | 3,573.449 | 3,573.449 | 0 | 679.183 | 0 |
Liabilities & Equity: | |||||||||||||||||||
Current Liabilities: | |||||||||||||||||||
Account Payables
| 129.939 | 129.939 | 141.661 | 152.214 | 116.648 | 127.887 | 132.158 | 156.765 | 92.714 | 95.1 | 129.666 | 153.477 | 92.208 | 104.537 | 108.754 | 108.754 | 0 | 112.79 | 0 |
Short Term Debt
| 1.113 | 1.113 | 3.231 | 3.231 | 9.871 | 9.871 | 6.763 | 6.763 | 14.778 | 14.778 | 37.301 | 37.301 | 14.864 | 14.864 | 15.045 | 15.045 | 0 | 13.451 | 0 |
Tax Payables
| 0 | 0 | 1.844 | 0 | 2.271 | 0 | 2.237 | 0 | 2.78 | 0 | 3.505 | 0 | 1.536 | 0 | 0 | 0 | 0 | 0.564 | 0 |
Deferred Revenue
| 0 | 0 | -3.066 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 58.586 | 58.586 | 82.789 | 74.08 | 91.004 | 82.036 | 119.237 | 96.867 | 123.862 | 124.256 | 142.716 | 122.41 | 154.048 | 143.255 | 124.931 | 124.931 | 0 | 263.355 | 0 |
Total Current Liabilities
| 189.638 | 189.638 | 229.525 | 229.525 | 219.794 | 219.794 | 260.395 | 260.395 | 234.134 | 234.134 | 313.188 | 313.188 | 262.656 | 262.656 | 248.73 | 248.73 | 0 | 390.16 | 0 |
Non-Current Liabilities: | |||||||||||||||||||
Long Term Debt
| 2.035 | 2.035 | 3.924 | 3.924 | 23.691 | 23.691 | 21.823 | 21.823 | 40.028 | 40.028 | 20.107 | 20.107 | 17.378 | 17.378 | 16.014 | 16.014 | 0 | 26.781 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 10.574 | 0 | 12.137 | 0 | 13.984 | 0 | 15.83 | 0 | 18.149 | 0 | 20.944 | 0 | 0 | 0 | 0 | 22.871 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 11.595 | 0 | 12.017 | 0 | 12.439 | 0 | 12.86 | 0 | 13.282 | 0 | 13.703 | 0 | 0 | 0 | 0 | 14.757 | 0 |
Other Non-Current Liabilities
| 19.306 | 19.306 | 22.728 | 22.728 | 25.062 | 25.062 | 1.232 | 27.655 | 32.047 | 32.047 | 36.435 | 36.435 | 67.346 | 67.346 | 71.58 | 71.58 | 0 | 116.461 | 0 |
Total Non-Current Liabilities
| 21.341 | 21.341 | 26.652 | 26.652 | 48.753 | 48.753 | 49.478 | 49.478 | 72.075 | 72.075 | 56.542 | 56.542 | 84.724 | 84.724 | 87.594 | 87.594 | 0 | 143.242 | 0 |
Total Liabilities
| 210.979 | 210.979 | 256.177 | 256.177 | 268.547 | 268.547 | 309.873 | 309.873 | 306.209 | 306.209 | 369.73 | 369.73 | 347.38 | 347.38 | 336.324 | 336.324 | 0 | 533.402 | 0 |
Equity: | |||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 1,430.161 | 0 | 1,452.204 | 0 | 1,450.434 | 0 | 1,409.824 | 0 | 1,375.106 | 0 | 0 | 0 | 0 | 181.371 | 0 |
Common Stock
| 0.07 | 0.07 | 0.069 | 0.069 | 0.069 | 0.069 | 0.069 | 0.069 | 0.069 | 0.069 | 0.068 | 0.068 | 0.067 | 0.067 | 0.067 | 0.067 | 0 | 0.039 | 0 |
Retained Earnings
| -6,916.031 | -6,916.031 | -6,790.336 | -6,790.336 | -6,390.526 | -6,390.526 | -6,115.974 | -6,115.974 | -5,791.391 | -5,791.391 | -5,385.76 | -5,385.76 | -4,921.429 | -4,921.429 | -4,520.536 | -4,520.536 | 0 | -1,635.399 | 0 |
Accumulated Other Comprehensive Income/Loss
| -1,493.499 | -1,493.499 | -1,413.572 | -1,413.572 | -1,430.161 | -1,430.161 | -1,452.204 | -1,452.204 | -1,450.434 | -1,450.434 | -1,409.824 | -1,409.824 | -1,375.106 | -1,375.106 | -1,426.445 | -1,426.445 | 139.859 | -181.371 | 823.604 |
Other Total Stockholders Equity
| 9,471.506 | 9,471.506 | 9,392.653 | 9,392.653 | 9,384.321 | 9,384.321 | 9,370.587 | 9,370.587 | 9,361.348 | 9,361.348 | 9,285.705 | 9,285.705 | 9,221.779 | 9,221.779 | 9,180.967 | 9,180.967 | 5.922 | 1,956.59 | 0 |
Total Shareholders Equity
| 1,062.046 | 1,062.046 | 1,188.814 | 1,188.814 | 1,563.703 | 1,563.703 | 1,802.478 | 1,802.478 | 2,119.592 | 2,119.592 | 2,490.189 | 2,490.189 | 2,925.311 | 2,925.311 | 3,234.053 | 3,234.053 | 145.781 | 139.859 | 823.604 |
Total Equity
| 1,063.342 | 1,063.342 | 1,190.7 | 1,190.7 | 1,565.952 | 1,565.952 | 1,805.218 | 1,805.218 | 2,121.527 | 2,121.527 | 2,493.111 | 2,493.111 | 2,926.732 | 2,926.732 | 3,237.125 | 3,237.125 | 145.781 | 145.781 | 823.604 |
Total Liabilities & Shareholders Equity
| 1,274.321 | 1,274.321 | 1,446.877 | 1,446.877 | 1,834.499 | 1,834.499 | 2,115.091 | 2,115.091 | 2,427.736 | 2,427.736 | 2,862.841 | 2,862.841 | 3,274.112 | 3,274.112 | 3,573.449 | 3,573.449 | 145.781 | 679.183 | 823.604 |